•Microbial metabolism of methotrexate produces a STAT3 signaling molecule that alleviates gut inflammation
•Performance of an infliximab precision-guided dosing tool from a capillary blood-based self-collection device in inflammatory bowel disease patients
•The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study
•Effects of upadacitinib on lipid profiles and their relationship with inflammation in patients with inflammatory bowel disease: a real-world longitudinal cohort study
•Microbes and TNF drive colitis in the absence of innate lymphoid cells